Verily Partners With Bausch + Lomb for Dry Eye App

The Verily Me app now features AI-guided tools to help users manage dry eye disease symptoms.

Updated on Oct. 15, 2026 in Healthcare

Isometric editorial illustration showing a stylized diagnostic lens and a geometric intelligence network, representing AI-assisted eye health technology. — Verily Health and Bausch + Lomb have partnered to integrate AI-guided symptom education and tools into the Verily Me application. AI Illustration. Upload story photo >

Live Poll

Do you trust AI-based mobile apps to provide accurate and reliable medical advice for your health?

Verily Health has partnered with Bausch + Lomb to integrate specialized dry eye disease education and support into the Verily Me app. The update utilizes the Verily Pre health intelligence platform to offer personalized symptom guidance.

Why it matters

This partnership aims to help millions of patients arrive at their eye care appointments better informed by providing accessible, AI-guided symptom support. By bridging the gap between daily symptoms and clinical visits, the initiative seeks to improve patient outcomes for a prevalent condition.

Approximately 150 million U.S. adults report occasional or frequent dry eye symptoms, with 38 million of those individuals living with a diagnosed case of the disease.

The players

Verily Health

An Alphabet company that focuses on life sciences and healthcare data to improve patient care through digital solutions.

Bausch + Lomb

A global eye health company that develops contact lenses, lens care products, and pharmaceutical treatments for ocular conditions.

The details

The application now includes an AI-guided symptom conversation tool called Vi, which reviews a user's health history and asks follow-up questions to provide tailored self-care advice. The system relies on clinically reviewed content and integrated safety checks to ensure accurate user interactions.

October 15, 2026: Verily Health and Bausch + Lomb announced the new partnership.

Market Landscape

This integration follows the established architectural standards of the Verily Pre health intelligence platform, scaling digital support for a chronic condition in a competitive health-tech sector. The move positions the companies to capture a larger share of the patient-engagement market by streamlining how individuals interact with clinical resources.

Users can now leverage the Vi AI tool to track their symptoms and receive self-care advice, potentially reducing the need for minor inquiries during office visits. Patients should consult their eye care provider to determine how this digital symptom support complements their existing treatment plan.

The takeaway

Using AI-guided symptom checkers can provide users with better clarity regarding their ocular health between professional appointments. Patients should remember that these tools are intended to support, not replace, formal clinical evaluations from eye care professionals.